Recombinant Human Nerve Growth Factor (Kerun Biopharmaceutical)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Human Nerve Growth Factor (Kerun Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR agonists
TargetsLow affinity neurotrophin receptor p75NTR
Therapy Area/IndicationsKeratitisXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
Inactive CompaniesN/A
Active IndicationsKeratitisXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A